Which of the following is NOT listed as a treatment option for pulmonary hypertension in the material?

Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

Which of the following is NOT listed as a treatment option for pulmonary hypertension in the material?

Pulmonary hypertension is managed with approaches that improve oxygenation, promote vasodilation when appropriate, and reduce thrombotic risk. The material lists oxygen therapy as needed to correct hypoxemia, inhaled nitric oxide for severe cases to provide rapid, selective pulmonary vasodilation, and anticoagulants to lower the risk of in-situ thrombosis in the pulmonary vessels. Calcium channel blockers are not listed among the treatment options in that material, so they are the option that does not fit the listed therapies. In practice, calcium channel blockers are considered only for a specific subset of patients who show vasoreactivity, and they are not universally applicable, which explains why they might be omitted from a general listing like the one in the material.

Pulmonary hypertension is managed with approaches that improve oxygenation, promote vasodilation when appropriate, and reduce thrombotic risk. The material lists oxygen therapy as needed to correct hypoxemia, inhaled nitric oxide for severe cases to provide rapid, selective pulmonary vasodilation, and anticoagulants to lower the risk of in-situ thrombosis in the pulmonary vessels. Calcium channel blockers are not listed among the treatment options in that material, so they are the option that does not fit the listed therapies. In practice, calcium channel blockers are considered only for a specific subset of patients who show vasoreactivity, and they are not universally applicable, which explains why they might be omitted from a general listing like the one in the material.

More practice questions